Over-rulling a group sequential boundary - A stopping rule versus a guideline

Statistics in Medicine

Volumn 22, Issue 21, 2003, Pages 3347-3355

  Gordon Lan, K K ^a   Lachin, John M ^b   Bautista, Oliver ^b  

^a PFIZER INC   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Group sequential analysis; Over ruling; Stopping guidelines; Stopping rules

Indexed keywords

ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; BIOSTATISTICS; CLINICAL RESEARCH; DIABETES CONTROL; DIABETIC RETINOPATHY; EXPERIMENTAL DESIGN; FOLLOW UP; HUMAN; OUTCOMES RESEARCH; PATIENT MONITORING; PRACTICE GUIDELINE; PROBABILITY; REFERENCE VALUE; SAMPLE SIZE; SEQUENTIAL ANALYSIS; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; BIOMETRY; CLINICAL TRIAL; METHODOLOGY; STATISTICAL MODEL; SYSTEM ANALYSIS;

BIOMETRY; CLINICAL TRIALS; HUMANS; MODELS, STATISTICAL; PROBABILITY THEORY;

EID: 1542681059     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1636     Document Type: Article

References (12)

1. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70:659-663.
2. Reboussin DM, DeMets DL, Kim K, Lan KKG. Computations for group sequential boundaries using the Lan-DeMets spending function method. Controlled Clinical Trials 2000; 190-207.
3. EaST 2000 User Manual. Cytel Software Corporation: Cambridge, MA, 2000.
4. Jennison C, Turnbull BW. Group Sequential Methods with Applications to Clinical Trials. Chapman & Hall/CRC; New York: 2000; 21:190-207.
5. Lan KKG, Demets DL, Halperin M. More flexible sequential and non-sequential designs in long-term clinical trials. Communications in Statistics 1984; A13:2339-2353.
6. Lan KKG, Wittes J. Data monitoring in complex clinical trials: Which treatment is better? Journal of Statistical planning and Inference 1994; 42:241-255.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993; 329:977-986.
8. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
9. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-199.
10. Tan M, Xiaon X, Kutner MH. Clinical trial designs based on sequential conditional probability ratio tests and reverse stochastic curtailing. Biometrics 1998; 54:682-695.
11. Pampallona S, Tsiatis AA, Kim K. Spending functions for type I and type II error probabilities of group sequential trials. Technical Report, Department of Biostatistics, Harvard School of Public Health, Boston, 1995.
12. Whitehead J. Overrunning and underrunning in sequential clinical trials. Controlled Clinical Trials 1992; 13: 106-121.